170 related articles for article (PubMed ID: 24307563)
1. Blood-based testing for colorectal cancer screening.
Heichman KA
Mol Diagn Ther; 2014 Apr; 18(2):127-35. PubMed ID: 24307563
[TBL] [Abstract][Full Text] [Related]
2. Colorectal cancer screening with blood-based biomarkers: cost-effectiveness of methylated septin 9 DNA versus current strategies.
Ladabaum U; Allen J; Wandell M; Ramsey S
Cancer Epidemiol Biomarkers Prev; 2013 Sep; 22(9):1567-76. PubMed ID: 23796793
[TBL] [Abstract][Full Text] [Related]
3. Septin 9 methylated DNA is a sensitive and specific blood test for colorectal cancer.
Warren JD; Xiong W; Bunker AM; Vaughn CP; Furtado LV; Roberts WL; Fang JC; Samowitz WS; Heichman KA
BMC Med; 2011 Dec; 9():133. PubMed ID: 22168215
[TBL] [Abstract][Full Text] [Related]
4. Prospective evaluation of methylated SEPT9 in plasma for detection of asymptomatic colorectal cancer.
Church TR; Wandell M; Lofton-Day C; Mongin SJ; Burger M; Payne SR; Castaños-Vélez E; Blumenstein BA; Rösch T; Osborn N; Snover D; Day RW; Ransohoff DF;
Gut; 2014 Feb; 63(2):317-25. PubMed ID: 23408352
[TBL] [Abstract][Full Text] [Related]
5. Performance of the colorectal cancer screening marker Sept9 is influenced by age, diabetes and arthritis: a nested case-control study.
Ørntoft MB; Nielsen HJ; Ørntoft TF; Andersen CL;
BMC Cancer; 2015 Oct; 15():819. PubMed ID: 26514170
[TBL] [Abstract][Full Text] [Related]
6. Detection of Colorectal Cancer Using a Simplified SEPT9 Gene Methylation Assay Is a Reliable Method for Opportunistic Screening.
Wu D; Zhou G; Jin P; Zhu J; Li S; Wu Q; Wang G; Sheng J; Wang J; Song L; Han X; Qian J
J Mol Diagn; 2016 Jul; 18(4):535-45. PubMed ID: 27133379
[TBL] [Abstract][Full Text] [Related]
7. Systematic review of blood diagnostic markers in colorectal cancer.
Nikolaou S; Qiu S; Fiorentino F; Rasheed S; Tekkis P; Kontovounisios C
Tech Coloproctol; 2018 Jul; 22(7):481-498. PubMed ID: 30022330
[TBL] [Abstract][Full Text] [Related]
8. The performance of the SEPT9 gene methylation assay and a comparison with other CRC screening tests: A meta-analysis.
Song L; Jia J; Peng X; Xiao W; Li Y
Sci Rep; 2017 Jun; 7(1):3032. PubMed ID: 28596563
[TBL] [Abstract][Full Text] [Related]
9. From discovery to the clinic: the novel DNA methylation biomarker (m)SEPT9 for the detection of colorectal cancer in blood.
Payne SR
Epigenomics; 2010 Aug; 2(4):575-85. PubMed ID: 22121975
[TBL] [Abstract][Full Text] [Related]
10. Detection of colorectal cancer by DNA methylation biomarker SEPT9: past, present and future.
Li Y; Song L; Gong Y; He B
Biomark Med; 2014; 8(5):755-69. PubMed ID: 25123042
[TBL] [Abstract][Full Text] [Related]
11. Multiplex methylated DNA testing in plasma with high sensitivity and specificity for colorectal cancer screening.
Zhao G; Li H; Yang Z; Wang Z; Xu M; Xiong S; Li S; Wu X; Liu X; Wang Z; Zhu Y; Ma Y; Fei S; Zheng M
Cancer Med; 2019 Sep; 8(12):5619-5628. PubMed ID: 31407497
[TBL] [Abstract][Full Text] [Related]
12. Epi proColon
Shirley M
Mol Diagn Ther; 2020 Aug; 24(4):497-503. PubMed ID: 32557236
[TBL] [Abstract][Full Text] [Related]
13. Sensitive detection of colorectal cancer in peripheral blood by septin 9 DNA methylation assay.
Grützmann R; Molnar B; Pilarsky C; Habermann JK; Schlag PM; Saeger HD; Miehlke S; Stolz T; Model F; Roblick UJ; Bruch HP; Koch R; Liebenberg V; Devos T; Song X; Day RH; Sledziewski AZ; Lofton-Day C
PLoS One; 2008; 3(11):e3759. PubMed ID: 19018278
[TBL] [Abstract][Full Text] [Related]
14. SEPT9: A Specific Circulating Biomarker for Colorectal Cancer.
Song L; Li Y
Adv Clin Chem; 2015; 72():171-204. PubMed ID: 26471083
[TBL] [Abstract][Full Text] [Related]
15. Application of droplet digital polymerase chain reaction of plasma methylated septin 9 on detection and early monitoring of colorectal cancer.
Ma ZY; Chan CSY; Lau KS; Ng L; Cheng YY; Leung WK
Sci Rep; 2021 Dec; 11(1):23446. PubMed ID: 34873218
[TBL] [Abstract][Full Text] [Related]
16. Use of NCCN Guidelines, Other Guidelines, and Biomarkers for Colorectal Cancer Screening.
Williams CD; Grady WM; Zullig LL
J Natl Compr Canc Netw; 2016 Nov; 14(11):1479-1485. PubMed ID: 27799515
[TBL] [Abstract][Full Text] [Related]
17. Molecular markers for colorectal cancer screening.
Dickinson BT; Kisiel J; Ahlquist DA; Grady WM
Gut; 2015 Sep; 64(9):1485-94. PubMed ID: 25994221
[TBL] [Abstract][Full Text] [Related]
18. Review of Blood-Based Colorectal Cancer Screening: How Far Are Circulating Cell-Free DNA Methylation Markers From Clinical Implementation?
Worm Ørntoft MB
Clin Colorectal Cancer; 2018 Jun; 17(2):e415-e433. PubMed ID: 29678513
[TBL] [Abstract][Full Text] [Related]
19. A systematic review of the performance of the SEPT9 gene methylation assay in colorectal cancer screening, monitoring, diagnosis and prognosis.
Song L; Yu H; Jia J; Li Y
Cancer Biomark; 2017; 18(4):425-432. PubMed ID: 28128742
[TBL] [Abstract][Full Text] [Related]
20. The role of
Sun J; Fei F; Zhang M; Li Y; Zhang X; Zhu S; Zhang S
BMC Cancer; 2019 May; 19(1):450. PubMed ID: 31088406
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]